NetworkNewsBreaks

ThursdaySep 04, 2025 10:18 am

NetworkNewsBreaks – Fifty 1 Labs, Inc. (OTC: FITY) Subsidiary Publishes Landmark Primer on Oncology Real-World Evidence

Fifty 1 Labs (OTC: FITY) through its subsidiary Fifty1 AI Labs, announced the publication of a landmark technical primer on transportability methods in oncology real-world evidence (RWE) in the Journal of Comparative Effectiveness Research. Co-authored by CTO Alind Gupta and CEO Paul Arora, the paper showcases how advanced statistical and AI-driven frameworks can bridge data gaps, accelerate health technology assessments, and improve global access to life-saving therapies. With the oncology RWE market projected to expand from $789 million in 2024 to $3.51 billion by 2035 at a CAGR of 14.7%, the publication underscores Fifty1 Labs’ leadership in advancing drug repurposing…

Continue Reading

ThursdaySep 04, 2025 10:10 am

NetworkNewsBreaks – Safe Pro Group Inc. (NASDAQ: SPAI) Subsidiary Wins Drone Services Contracts with Florida Utilities

Safe Pro Group (NASDAQ: SPAI), a provider of AI-powered defense and security solutions, announced that its Mission Critical Unmanned Solutions(R) subsidiary, Airborne Response, has been awarded two aerial drone services contracts by Florida power utilities serving millions of residents. The agreements cover disaster response imagery to assess storm damage to power grid infrastructure as well as “blue sky” condition assessments. With NOAA forecasting a 60% chance of above-average Atlantic storm activity in 2025, Airborne’s Florida-compliant drone fleet is positioned to support utilities in maintaining reliable power while expanding its role as a leading provider of infrastructure inspection, monitoring, and emergency…

Continue Reading

ThursdaySep 04, 2025 9:50 am

NetworkNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) CEO Featured on IBN’s BioMedWire Podcast

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company developing the IzoView Breast CT Imaging System, was featured in the latest episode of IBN’s BioMedWire Podcast. CEO Robert Thast discussed the company’s mission to improve early breast cancer detection, noting IzoView’s ability to identify cancers as small as 2 millimeters compared to the 11-millimeter average under current standards of care. Thast also outlined Izotropic’s intellectual property portfolio, AI-driven advancements, competitive outlook, and commercialization strategy in Europe and the U.S., adding that the company could be a takeover target as demand for innovative breast imaging solutions grows. To view…

Continue Reading

ThursdaySep 04, 2025 9:41 am

NetworkNewsBreaks – PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) to Present at ArcStone-Kingswood Growth Summit in Toronto 

Disseminated on behalf of PowerBank Corporation   PowerBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE:103) announced its participation in the ArcStone-Kingswood Growth Summit on Sept. 18, 2025, at the St. Regis Toronto. President and CEO Dr. Richard Lu will present on the company’s recent milestones and future growth strategy. The event will feature more than 20 high-growth companies alongside institutional and retail investors, with keynote presentations, panel discussions, and 1-on-1 meetings focused on connecting investors with new opportunities. To view the full press release, visit https://nnw.fm/TaFrr About PowerBank PowerBank Corporation is an independent renewable and clean energy project developer and owner focusing…

Continue Reading

ThursdaySep 04, 2025 9:30 am

NetworkNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Acquires 22,000-Square-Foot Facility to Advance Addiction Treatment Solutions

Branded Legacy (OTC: BLEG), a biotechnology company focused on addiction treatment and harm reduction, announced that its subsidiary, BioLegacy Evaluative Group, has acquired a 22,000-square-foot commercial property in Vancouver, Canada. The new GMP-compliant facility, equipped with ISO Class 7 and 8 clean rooms, will serve as a laboratory and manufacturing hub to support the development of safe, effective devices and products designed to counteract hazardous substances and reduce associated harms. Strategically located in the center of Vancouver’s drug crisis, the site will enable BioLegacy to collaborate directly with affected populations while advancing technologies supported by partnerships with McMaster University and Stanford…

Continue Reading

ThursdaySep 04, 2025 9:20 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures $5.3 Million from Warrant Exercises to Advance AVERSA Fentanyl NDA

Nutriband (NASDAQ: NTRB), a company developing abuse deterrent pharmaceutical products, announced the exercise of warrants at a strike price of $6.43, generating $5,306,000 in proceeds. The funds will support the remaining clinical development of AVERSA Fentanyl and submission of its New Drug Application (NDA) with the U.S. Food and Drug Administration. AVERSA Fentanyl, which could become the world’s first opioid patch with abuse deterrent properties, is estimated to reach peak annual U.S. sales of $80 million to $200 million, according to a 2022 Health Advances market analysis report. To view the full press release, visit https://nnw.fm/EspWP About Nutriband Inc. We…

Continue Reading

ThursdaySep 04, 2025 9:00 am

NetworkNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Launches Redesigned Corporate Website to Mark Turnaround and Growth Phase

SEGG Media (NASDAQ: SEGG, LTRYW), a sports, entertainment and gaming conglomerate that owns Sports.com, Concerts.com and Lottery.com, announced the launch of its newly redesigned corporate website, seggmediacorp.com, a digital hub signaling the completion of the Company’s turnaround and the start of its next phase of growth. The site highlights SEGG Media’s evolution into a content-first platform focused on fan engagement, younger audiences and immersive digital experiences, while centralizing access to Sports.com, Concerts.com and Lottery.com. The relaunch underscores SEGG Media’s unified corporate identity, investor transparency, fan engagement initiatives and ecosystem integration, positioning the Company as a forward-thinking media brand built for…

Continue Reading

WednesdaySep 03, 2025 1:45 pm

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Completes FDA Type C Meeting, Gains Guidance for Planned Pediatric CNS Cancer Trial 

Lantern Pharma (NASDAQ: LTRN), an AI-driven clinical-stage oncology company, announced the completion of a Type C meeting with the U.S. Food and Drug Administration, which provided guidance on the regulatory pathway and design of a planned pediatric trial targeting CNS cancers, including Atypical Teratoid Rhabdoid Tumor (ATRT). The FDA supported Lantern’s proposal for a parallel ATRT cohort and the potential inclusion of spironolactone as a combination agent with LP-184/STAR-001, the company’s lead investigational therapy. Lantern, through its subsidiary Starlight Therapeutics, will submit an IND amendment reflecting the feedback, with trial initiation targeted for Q1 2026. The program holds Rare Pediatric…

Continue Reading

WednesdaySep 03, 2025 1:33 pm

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Spotlighted in Forbes Feature on AI and Web3 Convergence

Datavault AI (NASDAQ: DVLT), a leader in tokenized data and Web3 infrastructure, was recently featured in Forbes in an article titled “How AI Is Ushering In A New Age For Web3” (Aug. 31, 2025). The piece highlights DVLT’s role in merging blockchain’s decentralized architecture with the adaptive intelligence of AI, underscoring how its secure, user-centric data platform enables seamless integration of tokenized assets and personalized digital interactions. As enterprises and developers look to bridge trust, transparency, and efficiency across decentralized ecosystems, DVLT is positioning itself as a cornerstone for the next generation of Web3 infrastructure. The Forbes coverage emphasized that…

Continue Reading

WednesdaySep 03, 2025 1:10 pm

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join H.C. Wainwright’s 27th Annual Global Investment Conference; CEO Fireside Chat Set for Sept. 8, 2025, 4:30 to 5 p.m. ET

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc. (“HOPE”), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, announced that Chairman and CEO Jonathan Javitt, M.D., M.P.H., will participate in a fireside chat at H.C. Wainwright’s 27th Annual Global Investment Conference on Monday, Sept. 8, 2025, from 4:30 to 5 p.m. ET. A webcast will be available on the Events page of the Investors section of the Company’s website, with a replay posted two hours after the event for 30 days. To view the full press release, visit https://nnw.fm/1yX7W About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc.…

Continue Reading